Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema? Amanda SutherlandJamie L. WagnerKelsey E. Larson Review 04 January 2021 Pages: 1 - 6
Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes Mahmoud Al-MasriBasim AljalabnehTamador Al-Shamaileh Review 21 January 2021 Pages: 7 - 13
Breast cancer in Colombia: a growing challenge for the healthcare system Carlos DuarteAlejandro SalazarPaul E. Goss Review 21 February 2021 Pages: 15 - 24
Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy Piriya LuangwattananunMutita JunkingPa-thai Yenchitsomanus Preclinical study 03 January 2021 Pages: 25 - 36
HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells Takaaki ObaMayu OnoKen-ichi Ito Preclinical study 16 January 2021 Pages: 37 - 51
Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population? Kaitlyn KennardMeghan E. BuckleyNed Z. Carp Preclinical study 03 January 2021 Pages: 53 - 63
ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes Elise KlæstadJoanna Ewa SawickaAnna Mary Bofin Preclinical study 02 January 2021 Pages: 65 - 77
N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target John R. MackeyJustine LaiLuc G. Berthiaume Preclinical study Open access 04 January 2021 Pages: 79 - 87
Cancer stem cell transcriptome landscape reveals biomarkers driving breast carcinoma heterogeneity Zhifa ZhangXiao ChenXiaofeng Dai Preclinical study 03 January 2021 Pages: 89 - 98
HER2 fluorescent in situ hybridization signal degradation: a 10-year retrospective study Jessie M. WuAndrey-Ann GaliboisGulisa Turashvili Preclinical study 03 January 2021 Pages: 99 - 105
A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia Mario E. LacoutureHedy DionShari B. Goldfarb Clinical trial 18 November 2020 Pages: 107 - 114
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer Juliet RichmanAlistair RingIvana Sestak Clinical trial Open access 21 November 2020 Pages: 115 - 123
Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean Breast Cancer Society Young-Joon KangSe Jeong OhYong-Seok Kim Clinical trial 03 January 2021 Pages: 125 - 134
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial) Shinji OhnoShigehira SajiYasuo Ohashi Clinical trial Open access 01 December 2020 Pages: 135 - 147
Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population Ziyao LiYing WangJiawei Tian Clinical trial 03 January 2021 Pages: 149 - 156
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer Tal SellaShari I. GelberAnn H. Partridge Epidemiology 04 November 2020 Pages: 157 - 165
Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion Vincent KoppelmansKimberly D. van der WillikSanne B. Schagen Epidemiology Open access 05 November 2020 Pages: 167 - 176
The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer Kelly A. MetcalfeAlexandra CandibSteven A. Narod Epidemiology 10 November 2020 Pages: 177 - 189
Association of relative dose intensity with BMI and pathologic complete response in patients treated with neoadjuvant chemotherapy for breast cancer Ilana UsiskinFangyong LiTara Sanft Epidemiology 30 October 2020 Pages: 191 - 197
Drug use disorder and risk of incident and fatal breast cancer: a nationwide epidemiological study Disa DahlmanHedvig MagnussonKristina Sundquist Epidemiology Open access 06 November 2020 Pages: 199 - 207
Presentation and characteristics of breast cancer in young women under age 40 Xueying HuKelly S. MyersEmily B. Ambinder Epidemiology 02 November 2020 Pages: 209 - 217
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment Emanuel RaschiMichele FusaroliFabrizio De Ponti Epidemiology Open access 05 November 2020 Pages: 219 - 227
Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey Anand K. NarayanSarah F. MercaldoRandy C. Miles Epidemiology 12 November 2020 Pages: 229 - 235
Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer Arran K. TurnbullSamir PatelOlga Oikonomidou Brief Report Open access 12 October 2020 Pages: 237 - 245
Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling Jian ZhangYang LiuCan Zhou Brief Report 09 January 2021 Pages: 247 - 258
Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations Hagit ShaniRinat Bernstein-MolhoEitan Friedman Brief Report 15 January 2021 Pages: 259 - 263
Germline BRCA-mutated metastatic breast cancer with positive hormone receptor Michela PalleschiMaria Laura IaiaChiara Casadei Letter to the Editor 10 November 2020 Pages: 265 - 266
Letter to the Editor regarding the publication titled “Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?” Rosa Di MiccoJean-Marc ClasseEUBREAST founding members Letter to the Editor 07 January 2021 Pages: 267 - 268
Letter to the editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer‑related lymphedema: a meta‑analysis comparing bioimpedance spectroscopy versus circumferential measurements” Bolette Skjødt RafnJan ChristensenKira Bloomquist Letter to the Editor 28 January 2021 Pages: 269 - 270
Letter to editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements” Cheryl L. BrunelleAndrea V. BarrioAlphonse G. Taghian Letter to the Editor 25 February 2021 Pages: 271 - 272
